Lamberti, Gianfranco
 Distribuzione geografica
Continente #
AS - Asia 97
NA - Nord America 70
EU - Europa 62
SA - Sud America 23
AF - Africa 6
Totale 258
Nazione #
US - Stati Uniti d'America 69
SG - Singapore 38
HK - Hong Kong 31
BR - Brasile 19
CN - Cina 13
RU - Federazione Russa 11
IE - Irlanda 10
DE - Germania 8
GB - Regno Unito 7
FR - Francia 5
SE - Svezia 5
VN - Vietnam 5
BJ - Benin 3
CZ - Repubblica Ceca 3
IT - Italia 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
KR - Corea 2
TR - Turchia 2
ZA - Sudafrica 2
BG - Bulgaria 1
CA - Canada 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
GR - Grecia 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
PL - Polonia 1
PY - Paraguay 1
UA - Ucraina 1
Totale 258
Città #
Hong Kong 31
Singapore 14
Ashburn 11
Beijing 11
Dublin 10
Los Angeles 5
Ho Chi Minh City 4
New York 4
Brooklyn 3
Cotonou 3
Falkenstein 3
London 3
Moscow 3
Nuremberg 3
Pardubice 3
Ankara 2
Buffalo 2
Milan 2
Seoul 2
São Paulo 2
Alameda 1
Ann Arbor 1
Athens 1
Augusta 1
Bexley 1
Blumenau 1
Campina Grande do Sul 1
Cape Town 1
Chandler 1
Chennai 1
City of London 1
Ciudad del Este 1
Dallas 1
Dhaka 1
Florianópolis 1
Frankfurt am Main 1
Gaiman 1
Giza 1
Goiânia 1
Grand Rapids 1
Guarapari 1
Guarulhos 1
Haiphong 1
Hangzhou 1
Helsinki 1
Horizonte 1
Jacksonville 1
Jaguaribe 1
Janaúba 1
Johannesburg 1
Kyiv 1
La Plata 1
Lawrence 1
Lexington Park 1
Manchester 1
Medianeira 1
Milwaukee 1
Montreal 1
Orem 1
Paranavaí 1
Paris 1
Piquet Carneiro 1
Pittsburgh 1
Poplar 1
Princeton 1
Quito 1
Rio de Janeiro 1
Rome 1
Roubaix 1
Sabará 1
San Francisco 1
San Jose 1
Santa Clara 1
Sidrolândia 1
Surakarta 1
São Bernardo do Campo 1
São Miguel do Araguaia 1
Tokyo 1
Vienna 1
Wilmington 1
Zanjan 1
Totale 182
Nome #
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC 55
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy 55
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations 52
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions 40
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer 32
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study 30
Totale 264
Categoria #
all - tutte 1.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 4 1 1 0 0 0 0 1 2 1
2022/202314 1 0 1 0 0 2 1 0 7 0 1 1
2023/202421 5 0 0 2 6 0 2 0 0 3 1 2
2024/202584 1 0 4 0 0 9 7 9 23 16 5 10
2025/2026135 16 19 17 44 35 4 0 0 0 0 0 0
Totale 264